Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5384)
All Articles published online
|
Jun 28, 2011 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lata J, Jurankova J, Kopacova M, Vitek P. Probiotics in hepatology. World J Gastroenterol 2011; 17(24): 2890-2896 [PMID: 21734800 DOI: 10.3748/wjg.v17.i24.2890] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i24/2890.htm |
| Number | Citing Articles |
| 1 |
Eamonn M.M. Quigley, Catherine Stanton, Eileen F. Murphy. The gut microbiota and the liver. Pathophysiological and clinical implications. Journal of Hepatology 2013; 58(5): 1020 doi: 10.1016/j.jhep.2012.11.023
|
| 2 |
Wei-Wei Wang, Yu Zhang, Xiao-Bing Huang, Nan You, Lu Zheng, Jing Li. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. World Journal of Gastroenterology 2017; 23(38): 6983-6994 doi: 10.3748/wjg.v23.i38.6983
|
| 3 |
Sara Ebrahimi-Mousavi, Seyed Moayed Alavian, Amir Ali Sohrabpour, Fatemeh Dashti, Kurosh Djafarian, Ahmad Esmaillzadeh. The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02176-2
|
| 4 |
Zelin Gu, Yanfeng Wu, Yu Wang, Haiyue Sun, Ying You, Chunhong Piao, Junmei Liu, Yuhua Wang. Lactobacillus rhamnosus Granules Dose-Dependently Balance Intestinal Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver Injury. Journal of Medicinal Food 2020; 23(2): 114 doi: 10.1089/jmf.2018.4357
|
| 5 |
Ruirui Zhu, Liwen Liu, Guizhen Zhang, Jianxia Dong, Zhigang Ren, Zhiqin Li. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis. Bioscience Reports 2023; 43(6) doi: 10.1042/BSR20222524
|
| 6 |
Hisashi Hidaka, Satoshi Tanabe, Haruki Uojima, Xue Shao, Shuichiro Iwasaki, Naohisa Wada, Kousuke Kubota, Yoshiaki Tanaka, Takahide Nakazawa, Akitaka Shibuya, Shigehiro Kokubu, Wasaburo Koizumi. Long‐term observation in patients with esophageal varices after endoscopic variceal ligation accompanied with 24‐hour pH monitoring. Hepatology Research 2020; 50(11): 1255 doi: 10.1111/hepr.13562
|
| 7 |
Dr Gopi SHAH. Ameliorating Potential of Marketed Formulations Containing Prebiotics And Probiotics Against Carbon Tetrachloride-Induced Hepatotoxicity in rats. Hacettepe University Journal of the Faculty of Pharmacy 2022; doi: 10.52794/hujpharm.1134688
|
| 8 |
Jun Xu, Rui Ma, Li-Feng Chen, Li-Jun Zhao, Kan Chen, Ren-Bing Zhang. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. Hepatobiliary & Pancreatic Diseases International 2014; 13(4): 354 doi: 10.1016/S1499-3872(14)60280-0
|
| 9 |
Azumi Ishizaki, Xiuqiong Bi, Lam Nguyen, Kazunori Matsuda, Hung Pham, Chung Phan, Dung Khu, Hiroshi Ichimura. Effects of Short-Term Probiotic Ingestion on Immune Profiles and Microbial Translocation among HIV-1-Infected Vietnamese Children. International Journal of Molecular Sciences 2017; 18(10): 2185 doi: 10.3390/ijms18102185
|
| 10 |
Garmen A. Woo, Christopher O'Brien. Long-term Management of Alcoholic Liver Disease. Clinics in Liver Disease 2012; 16(4): 763 doi: 10.1016/j.cld.2012.08.007
|
| 11 |
Eamonn M Quigley, Howard P Monsour. The gut microbiota and the liver: implications for clinical practice. Expert Review of Gastroenterology & Hepatology 2013; 7(8): 723 doi: 10.1586/17474124.2013.848167
|
| 12 |
Tannaz Ranjbarian, Bernd Schnabl. Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease. Seminars in Liver Disease 2023; 43(03): 311 doi: 10.1055/a-2145-7331
|
| 13 |
Mehmet Öztürk, Merve Meterelliyöz. Practical identification of human originated Lactobacillus species by amplified ribosomal DNA restriction analysis (ARDRA) for probiotic use. Molecular Biology Reports 2015; 42(8): 1323 doi: 10.1007/s11033-015-3877-7
|
| 14 |
Hiroshi Fukui. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World Journal of Hepatology 2015; 7(3): 425-442 doi: 10.4254/wjh.v7.i3.425
|
| 15 |
David W. Victor, Eamonn M.M. Quigley. Hepatic Encephalopathy Involves Interactions Among the Microbiota, Gut, Brain. Clinical Gastroenterology and Hepatology 2014; 12(6): 1009 doi: 10.1016/j.cgh.2014.01.022
|
| 16 |
Maha M. Bikheet, Magda E. Mahmoud, Eman E. Yassien, Hanaa M. Hassan. Effect of lactic acid bacteria isolated from some fermented dairy products on carbon tetrachloride-induced hepatotoxicity and nephrotoxicity of albino rats. Environmental Science and Pollution Research 2022; 29(8): 11790 doi: 10.1007/s11356-021-16524-4
|
| 17 |
Matthew A. Ciorba. A Gastroenterologist's Guide to Probiotics. Clinical Gastroenterology and Hepatology 2012; 10(9): 960 doi: 10.1016/j.cgh.2012.03.024
|
| 18 |
Zelin Gu, Yanlong Liu, Shumeng Hu, Ying You, Wancong Li, Yuhua Wang. Probiotics for Alleviating Alcoholic Liver Injury. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/9097276
|
| 19 |
Elisabet Sánchez, Juan C. Nieto, Ana Boullosa, Silvia Vidal, Francesc J. Sancho, Giacomo Rossi, Pau Sancho‐Bru, Rosa Oms, Beatriz Mirelis, Cándido Juárez, Carlos Guarner, Germán Soriano. VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride‐induced cirrhosis. Liver International 2015; 35(3): 735 doi: 10.1111/liv.12566
|
| 20 |
Lingchong Liu, Yu Wang, Jing Zhang, Chao Wang, Youbao Li, Weichang Dai, Chunhong Piao, Junmei Liu, Hansong Yu, Xia Li, Yuhua Wang, Jingsheng Liu. Probiotics in treating with alcoholic liver disease and nonalcoholic fatty liver disease. Food Reviews International 2023; 39(5): 2723 doi: 10.1080/87559129.2021.1967380
|
| 21 |
Mayank Sharma, Sanjay Bhat, Kalyan Dutt, Pulkit Sharma, Jasra Ali Bhat. RANDOMIZED CONTROLLED TRIAL OF LACTULOSE AND LACTULOSE PLUS PROBIOTICS IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY. Journal of Evidence Based Medicine and Healthcare 2014; 1(9): 1125 doi: 10.18410/jebmh/2014/166
|
| 22 |
Andreas Pfützner, Anke Pfützner, Mina Hanna, Filiz Demircik, Daniela Sachsenheimer, Tobias Wittig, Johan de Faire. Impact of a Single Dose of a Probiotic Nutritional Supplement (AB001) on Absorption of Ethylalcohol: Results From a Randomized Double-Blind Crossover Study. Nutrition and Metabolic Insights 2023; 16: 117863882211411 doi: 10.1177/11786388221141174
|
| 23 |
Jiaxin Zhang, Xiaobin Zao, Jiaying Zhang, Ziwei Guo, Qian Jin, Guang Chen, Da'nan Gan, Hongbo Du, Yong'an Ye. Is it possible to intervene early cirrhosis by targeting toll-like receptors to rebalance the intestinal microbiome?. International Immunopharmacology 2023; 115: 109627 doi: 10.1016/j.intimp.2022.109627
|
| 24 |
Julian R Marchesi, David H Adams, Francesca Fava, Gerben D A Hermes, Gideon M Hirschfield, Georgina Hold, Mohammed Nabil Quraishi, James Kinross, Hauke Smidt, Kieran M Tuohy, Linda V Thomas, Erwin G Zoetendal, Ailsa Hart. The gut microbiota and host health: a new clinical frontier. Gut 2016; 65(2): 330 doi: 10.1136/gutjnl-2015-309990
|
| 25 |
Chandana Pande, Ashish Kumar, Shiv Kumar Sarin. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology 2012; 24(7): 831 doi: 10.1097/MEG.0b013e3283537d61
|
| 26 |
S. Nabavi, M. Rafraf, M.H. Somi, A. Homayouni-Rad, M. Asghari-Jafarabadi. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. Journal of Dairy Science 2014; 97(12): 7386 doi: 10.3168/jds.2014-8500
|
| 27 |
|
| 28 |
Edna Strauss. The impact of bacterial infections on survival of patients with decompensated cirrhosis. Annals of Hepatology 2014; 13(1): 7 doi: 10.1016/S1665-2681(19)30899-3
|
| 29 |
Safoora Nabavi, Maryam Rafraf, Mohammad-hossein Somi, Aziz Homayouni-Rad, Mohammad Asghari-Jafarabadi. Probiotic yogurt improves body mass index and fasting insulin levels without affecting serum leptin and adiponectin levels in non-alcoholic fatty liver disease (NAFLD). Journal of Functional Foods 2015; 18: 684 doi: 10.1016/j.jff.2015.08.031
|
| 30 |
Samaneh Hadipour Ahmadi, Abdolrasoul Daneshjoo. The effect of aerobic training and probiotic intake on gene ICAM–1
expression in rats with nonalcoholic fatty liver. Journal of Sports Physiology and Athletic Conditioning 2021; 1(1): 54 doi: 10.61186/jspac.19946.1.1.54
|
| 31 |
Thierry Thevenot, Gilles Blasco, Natacha Grelat, Sébastien Pili-Floury. L’antibioprophylaxie primaire de l’infection spontanée d’ascite du patient cirrhotique est une affaire de cible !. La Presse Médicale 2012; 41(12): 1168 doi: 10.1016/j.lpm.2012.07.021
|
| 32 |
German Soriano, Carlos Guarner. Probiotics in cirrhosis: do we expect too much?. Liver International 2013; 33(10): 1451 doi: 10.1111/liv.12288
|
| 33 |
Manish Kumar Lunia, Barjesh Chander Sharma, Praveen Sharma, Sanjeev Sachdeva, Siddharth Srivastava. Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 2014; 12(6): 1003 doi: 10.1016/j.cgh.2013.11.006
|
| 34 |
E. Ramos-Tovar, P. Muriel. Liver Pathophysiology. 2017; : 743 doi: 10.1016/B978-0-12-804274-8.00053-9
|
| 35 |
Thierry Thevenot, Thibault Degand, Natacha Grelat, Laure Elkrief, Camille Christol, Richard Moreau, Jean Henrion, Jean‐François Cadranel, Frances Sheppard, Christophe Bureau, Vincent di Martino, Arnaud Pauwels. A French national survey on the use of antibiotic prophylaxis in cirrhotic patients. Liver International 2013; 33(3): 389 doi: 10.1111/liv.12093
|
| 36 |
Rebecca D. Norton, Catherine E. Lenox, Paul Manino, James C. Vulgamott. Nutritional Considerations for Dogs and Cats with Liver Disease. Journal of the American Animal Hospital Association 2016; 52(1): 1 doi: 10.5326/JAAHA-MS-6292R2
|
| 37 |
Eva Román, Juan Camilo Nieto, Cristina Gely, Sílvia Vidal, Marta Pozuelo, Maria Poca, Cándido Juárez, Carlos Guarner, Chaysavanh Manichanh, Germán Soriano. Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial. Hepatology Communications 2019; 3(5): 632 doi: 10.1002/hep4.1325
|
| 38 |
Norberto C. Chávez-Tapia, Leticia González-Rodríguez, MinSeung Jeong, Yanine López-Ramírez, Varenka Barbero-Becerra, Eva Juárez-Hernández, Juan L. Romero-Flores, Marco Arrese, Nahúm Méndez-Sánchez, Misael Uribe. Current evidence on the use of probiotics in liver diseases. Journal of Functional Foods 2015; 17: 137 doi: 10.1016/j.jff.2015.05.009
|
| 39 |
Xiao-Meng WANG, Xiao-Bo LI, Ying PENG. Impact of Qi -invigorating traditional Chinese medicines on intestinal flora: A basis for rational choice of prebiotics. Chinese Journal of Natural Medicines 2017; 15(4): 241 doi: 10.1016/S1875-5364(17)30041-9
|
| 40 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
|
| 41 |
Robert S. Lo, Andrew S. Austin, Jan G. Freeman. Association of Mannose-Binding Lectin Gene Polymorphisms with Liver Diseases: A Review. Open Medicine Journal 2018; 5(1): 39 doi: 10.2174/1874220301805010039
|
| 42 |
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
|
| 43 |
Ding Shi, Longxian Lv, Daiqiong Fang, Wenrui Wu, Chenxia Hu, Lichen Xu, Yanfei Chen, Jing Guo, Xinjun Hu, Ang Li, Feifei Guo, Jianzhong Ye, Yating Li, Dewi Andayani, Lanjuan Li. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-07091-1
|
| 44 |
Sudhir Maharshi, Barjesh Chander Sharma. Diagnosis and Management of Hepatic Encephalopathy. 2018; : 99 doi: 10.1007/978-3-319-76798-7_7
|
| 45 |
Long Huang, Qingsheng Yu, Hui Peng, Zhou Zhen. Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis. Medicine 2022; 101(51): e32335 doi: 10.1097/MD.0000000000032335
|
| 46 |
Antonella Borrelli, Patrizia Bonelli, Franca Maria Tuccillo, Ira D. Goldfine, Joseph L. Evans, Franco Maria Buonaguro, Aldo Mancini. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. Redox Biology 2018; 15: 467 doi: 10.1016/j.redox.2018.01.009
|
| 47 |
Jianwen Jiang, Zhigang Ren, Shusen Zheng. Infectious Microecology. Advanced Topics in Science and Technology in China 2014; : 333 doi: 10.1007/978-3-662-43883-1_13
|
| 48 |
Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci, Guglielmo M Trovato. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics. EPMA Journal 2014; 5(1) doi: 10.1186/1878-5085-5-21
|
| 49 |
Yasushi Okura, Tadashi Namisaki, Shinya Sato, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Kenichiro Seki, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Yukihisa Fujinaga, Takuya Kubo, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Koh Kitagawa, Tsuyoshi Mashitani, Hiroyuki Ogawa, Koji Ishida, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Hepatology Research 2019; 49(2): 232 doi: 10.1111/hepr.13249
|